Literature DB >> 6842024

Pathophysiology and immunology of the Jarisch-Herxheimer-like reaction in louse-borne relapsing fever: comparison of tetracycline and slow-release penicillin.

D A Warrell, P L Perine, D W Krause, D H Bing, S J MacDougal.   

Abstract

Twelve men with louse-borne relapsing fever were treated with single doses of procaine penicillin plus aluminum monostearate (PAM) intramuscularly or of tetracycline intravenously. All patients experienced a definite Jarisch-Herxheimer-like reaction. Fever and spirochetemia were significantly prolonged and peak temperature was lower and occurred later in the PAM-treated group. Peak pulmonary ventilation, metabolic rate, and arterial PO2 were significantly higher in the tetracycline-treated group. Circulatory changes were similar in the two groups but were prolonged in the PAM-treated patients. Thus, tetracycline is recommended for treatment because it is more rapidly effective in eliminating Borrelia spirochetes and produces a reaction no more stressful physiologically than the one after PAM. There was no evidence of complement activation, and there was no change in immunoglobulin levels throughout the reaction. Immune complexes were detected in serum of five patients before treatment, but in fewer patients at the peak of the reaction and subsequently.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6842024     DOI: 10.1093/infdis/147.5.898

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  The Jarisch-Herxheimer Reaction After Antibiotic Treatment of Spirochetal Infections: A Review of Recent Cases and Our Understanding of Pathogenesis.

Authors:  Thomas Butler
Journal:  Am J Trop Med Hyg       Date:  2016-10-24       Impact factor: 2.345

Review 2.  Antibiotic-induced release of endotoxin. A therapeutic paradox.

Authors:  J C Hurley
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

3.  Late relapse of tick-borne relapsing fever following treatment with doxycycline.

Authors:  W C Liles; D H Spach
Journal:  West J Med       Date:  1993-02

4.  Serodiagnosis of Louse-Borne relapsing fever with glycerophosphodiester phosphodiesterase (GlpQ) from Borrelia recurrentis.

Authors:  S F Porcella; S J Raffel; M E Schrumpf; M E Schriefer; D T Dennis; T G Schwan
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

Review 5.  Pathogenesis of Relapsing Fever.

Authors:  Job Lopez; Joppe W Hovius; Sven Bergström
Journal:  Curr Issues Mol Biol       Date:  2020-12-29       Impact factor: 2.081

Review 6.  Louse-borne relapsing fever (Borrelia recurrentis infection).

Authors:  David A Warrell
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

7.  Louse-borne relapsing fever-A systematic review and analysis of the literature: Part 2-Mortality, Jarisch-Herxheimer reaction, impact on pregnancy.

Authors:  Pascal Kahlig; Andreas Neumayr; Daniel H Paris
Journal:  PLoS Negl Trop Dis       Date:  2021-03-11

Review 8.  The Jarisch-Herxheimer reaction in leptospirosis: a systematic review.

Authors:  Gilles Guerrier; Eric D'Ortenzio
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.